Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Bio Rad Laboratories stock

BIO
US0905722072
865406

Price

336.28
Today +/-
-3.55
Today %
-1.10 %

Bio Rad Laboratories stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Bio Rad Laboratories stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Bio Rad Laboratories stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Bio Rad Laboratories stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Bio Rad Laboratories's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Bio Rad Laboratories Stock Price History

DateBio Rad Laboratories Price
12/13/2024336.28 undefined
12/12/2024340.01 undefined
12/11/2024341.51 undefined
12/10/2024339.87 undefined
12/9/2024345.60 undefined
12/6/2024325.50 undefined
12/5/2024322.36 undefined
12/4/2024338.44 undefined
12/3/2024332.28 undefined
12/2/2024338.77 undefined
11/29/2024340.53 undefined
11/27/2024338.48 undefined
11/26/2024337.73 undefined
11/25/2024336.09 undefined
11/22/2024332.91 undefined
11/21/2024325.58 undefined
11/20/2024323.69 undefined
11/19/2024320.66 undefined
11/18/2024313.15 undefined
11/15/2024320.31 undefined

Bio Rad Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Bio Rad Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bio Rad Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bio Rad Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bio Rad Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bio Rad Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bio Rad Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bio Rad Laboratories’s growth potential.

Bio Rad Laboratories Revenue, EBIT and net profit per share

DateBio Rad Laboratories RevenueBio Rad Laboratories EBITBio Rad Laboratories Net Income
2028e3.04 B undefined531.26 M undefined378.39 M undefined
2027e2.92 B undefined489.85 M undefined350.95 M undefined
2026e2.83 B undefined432.2 M undefined370.02 M undefined
2025e2.7 B undefined389.41 M undefined329.49 M undefined
2024e2.61 B undefined342.05 M undefined290.56 M undefined
20232.67 B undefined365.7 M undefined-637.32 M undefined
20222.8 B undefined486.8 M undefined-3.63 B undefined
20212.92 B undefined564.7 M undefined4.25 B undefined
20202.55 B undefined421.3 M undefined3.81 B undefined
20192.31 B undefined254.5 M undefined1.76 B undefined
20182.29 B undefined195.1 M undefined365.6 M undefined
20172.16 B undefined160.4 M undefined122.2 M undefined
20162.07 B undefined130.5 M undefined26 M undefined
20152.02 B undefined166.7 M undefined113.1 M undefined
20142.18 B undefined150 M undefined88.8 M undefined
20132.13 B undefined169.5 M undefined77.8 M undefined
20122.07 B undefined264.2 M undefined165.5 M undefined
20112.07 B undefined305.2 M undefined179 M undefined
20101.93 B undefined284 M undefined185.5 M undefined
20091.78 B undefined234.8 M undefined144.6 M undefined
20081.76 B undefined211.7 M undefined89.5 M undefined
20071.46 B undefined142.9 M undefined93 M undefined
20061.27 B undefined150.2 M undefined103.3 M undefined
20051.18 B undefined115.3 M undefined81.6 M undefined
20041.09 B undefined123.4 M undefined68.2 M undefined

Bio Rad Laboratories Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.070.080.10.130.160.20.240.290.310.330.330.360.40.420.430.450.560.730.820.870.981.091.181.271.461.761.781.932.072.072.132.182.022.072.162.292.312.552.922.82.672.612.72.832.923.04
-29.2321.4323.5326.1924.5319.1921.198.396.45-0.618.2311.556.822.133.4724.1630.6312.695.8813.1811.348.357.7914.7720.741.138.027.58-0.193.042.02-7.172.434.455.970.9610.1314.81-4.11-4.68-2.433.614.783.254.04
52.3151.1952.9455.5656.6056.0656.3656.9956.7758.1853.9656.0656.5756.9756.0254.8154.0552.0055.6957.6956.7955.9654.7055.9354.1454.5456.0056.6256.8355.8255.2554.1655.5255.1355.0553.6554.5756.4656.9155.9653.5454.8752.9650.5548.9647.05
0.030.040.050.070.090.110.130.160.180.190.180.20.220.240.240.250.30.380.460.50.560.610.650.710.790.9611.091.181.161.181.181.121.141.191.231.261.441.661.571.4300000
0000.010.010.010.010.010.010.0200.020.030.030.020.020.010.030.040.070.080.070.080.10.090.090.140.190.180.170.080.090.110.030.120.371.763.814.25-3.63-0.640.290.330.370.350.38
--200.0066.6740.0028.57-11.11-20.0087.50-86.67650.0066.674.00-38.4650.00-54.17181.8241.9452.2713.43-10.5319.1227.16-9.71-4.3061.8028.47-3.24-7.82-53.3314.2928.41-76.99369.23199.18381.64116.9511.54-185.26-82.44-145.5313.4512.46-5.418.00
19.219.319.521.822.722.722.923.523.623.82424.224.924.924.824.724.324.625.42626.326.526.726.927.327.627.828.228.528.628.929.129.429.63030.230.230.230.229.829.2100000
----------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Bio Rad Laboratories Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Bio Rad Laboratories is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                                                 
000.01000000.010000.020.010.010.010.020.010.050.030.150.360.410.490.220.240.751.030.810.920.610.70.790.840.760.851.120.990.871.791.61
131923293947597176767682929897106194182194209234261247293358340346388399399423378391372465392393419424495489.02
00000000000000000000000000000000000000000
16192126374453637282727375709192126133139166190206212253321376351398434455516471490525595584554622572719780.52
6104477911142018201922292742415163828013596126135121164153161210170109108162202119107125153171.65
0.040.050.050.060.090.10.120.150.170.180.170.180.20.20.230.240.380.370.430.470.660.911.011.131.031.091.561.981.81.941.761.721.781.841.982.022.182.141.993.163.05
16121424404450567783817673727982126119133142179202180190272301302334350417414429438489493509701694716680723.74
0.01000.0100.010.0100000.010.010.010.020.0100000000000000.290.380.390.720.831.032.664.649.5614.398.837.7
00000000000000000000000000000000000000000
0000000000000000000012592845210229205204259261266254214162174133146199254332320.51
00000000000000211910591787070113113119328322328364469495518500496477506220264292347406413.57
2325344565655772558674342768996113132921381862214055526548957080871049594.85
0.030.020.020.040.050.050.060.070.090.090.090.090.080.090.130.130.290.280.250.250.340.460.420.470.940.940.971.091.31.511.631.621.932.012.33.595.8310.8315.8110.349.25
0.060.070.070.10.130.160.180.210.250.270.260.270.290.290.350.370.670.650.690.720.991.371.421.61.972.042.543.063.13.443.393.343.713.854.275.618.0112.9717.813.512.3
                                                                                 
347888888888812121212000000000000000000000000
43713141414161617181920171819193232364250607899124130157185212240271300333361394410429442447449.08
0.010.010.020.020.030.040.050.060.060.080.080.10.130.150.170.190.20.230.280.350.420.490.570.670.760.8511.181.361.531.611.71.811.841.833.725.479.2713.539.99.26
00012213210344-10-5-13-232335827671116513319819927534121913-1755-50-95273-181-457-336.94
0000-1-1-1-200011161000000000000000036943568437106-100.9
0.020.020.030.040.050.060.070.080.090.110.110.130.160.190.20.220.230.250.290.380.50.60.660.820.971.041.261.541.742.022.192.192.492.592.934.075.799.9813.799.889.37
455910151719171915212021322765636550547173839611893113129131149129122133135122107139142135429.18
0000000000002424252760525863106168171133171150173155138166161153158163172144215259313231180.31
68101417223238434342473229333456566688696672100131140148165191174177164161175195184157231225202197.38
00000000000000000000000000000000000000000
57911191625283236312214611922181071093316105233122000004262000.49
152024344653748592988890908010197203189199208239314319319414418419666459473489446441471502450905631680568807.35
0.030.030.020.020.030.040.040.040.070.060.050.030.020.010.040.040.240.20.190.110.230.430.430.430.440.450.740.730.730.730.440.440.430.430.440.440.010.010.011.21.2
000000.010.010.010.010.010.010.020.020.020.020.010.010.010.010.010.02000.010.050.040.040.060.090.120.160.160.230.220.220.5512.083.071.771.48
000000000000000000013172921245860566576108117119111135183148337372358350360.59
0.030.030.020.020.040.040.040.050.070.070.060.040.040.020.050.060.250.210.20.130.260.460.450.460.550.550.840.860.890.960.720.710.780.790.841.141.352.463.433.323.04
0.050.050.040.060.080.10.120.130.160.170.150.130.130.10.160.150.450.40.40.340.50.770.770.780.970.971.261.521.351.431.21.161.221.261.341.592.253.094.113.893.84
0.060.070.070.10.130.160.180.220.250.270.260.270.290.290.360.370.680.650.690.720.991.371.431.61.942.012.523.063.13.443.393.343.713.854.275.668.0513.0717.9113.7613.22
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Bio Rad Laboratories provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Bio Rad Laboratories's financial health and stability.

Assets

Bio Rad Laboratories's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Bio Rad Laboratories must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Bio Rad Laboratories after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Bio Rad Laboratories's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00000000000000000000000000000000000000
00000000000000000000000000000000000000
00000000000000000000000000000000000000
-10-1-2-1-2210-60000-2-10501815-23181909715-33121103432184785108
0000000000000000000050791010131314171923273541516061
-2-3-4-5-7-7-9-8-6-4-3-1-3-9-23-22-25-17-19-31-31-30-30-38-59-56-46-61-20-20-22-22-22-22-21-2-24-47
-3-5-4-5-2-8-140-2-5-16-11-9-17-12-5-43-51-33-39-16-38-49-37-55-68-93-71-28-31-38-52-62-45-65-134-158-129
70891244224838332127452499105127123108118191191325225262276175273186216104285457585669194374
-20-11-9-13-13-31-20-14-9-12-15-23-21-27-31-43-42-69-60-36-53-60-84-66-87-102-152-113-121-112-141-111-129-98-108-133-112-156
-22-14-10-16-17-26-12-8-13-13-14-55-25-2239-47-54-190-186-6-207-254-146-176-216-386-409-5-190-166-213-175-187-208-69-797-1,20720
-2-2-1-3-4485-3-10-32-4-19640-4-12-121-12529-154-193-61-109-129-283-257107-69-54-72-64-57-11038-663-1,094176
00000000000000000000000000000000000000
00.0200.010.010.020-0.02-0.03-0.01-0.020.0400.19-0.04-0.02-0.080.120.19-0.01-0-0.02-0.010.290.22-0.230-0.3-0000-00-0.43-01.190
70001000010-3-202455789111210121410111581111-34-11-79-29-198-410
1115367251-15-32-13-25330182-41-20-79108193110-76293228-21312-31111890-48-22-523-55973-425
0000000000000-5-400-14-20135-2-122-22-10-2-11-10-11-16-23-14-14
00000000000000000000000000000000000000
109212223254316459493439806715415523129726411517931283759746298160437270263105385721658562254413
-12.8-12-0.6-3.6-1.3-26.9-16.4838.525.918-2.56.117.7-7.256.363.658.662.672.265.2131106.6258.3138.6159.8123.662.5152.374.274.7-7.2155.7359.4476.4535.881.6218.26
00000000000000000000000000000000000000

Bio Rad Laboratories stock margins

The Bio Rad Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bio Rad Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bio Rad Laboratories.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bio Rad Laboratories's sales revenue. A higher gross margin percentage indicates that the Bio Rad Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bio Rad Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bio Rad Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bio Rad Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bio Rad Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bio Rad Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bio Rad Laboratories Margin History

Bio Rad Laboratories Gross marginBio Rad Laboratories Profit marginBio Rad Laboratories EBIT marginBio Rad Laboratories Profit margin
2028e53.56 %17.48 %12.45 %
2027e53.56 %16.76 %12.01 %
2026e53.56 %15.28 %13.08 %
2025e53.56 %14.42 %12.2 %
2024e53.56 %13.13 %11.15 %
202353.56 %13.69 %-23.86 %
202255.97 %17.37 %-129.45 %
202156.91 %19.32 %145.57 %
202056.49 %16.55 %149.84 %
201954.57 %11.01 %76.08 %
201853.66 %8.52 %15.97 %
201755.06 %7.43 %5.66 %
201655.14 %6.31 %1.26 %
201555.55 %8.25 %5.6 %
201454.18 %6.9 %4.08 %
201355.26 %7.95 %3.65 %
201255.83 %12.77 %8 %
201156.85 %14.72 %8.63 %
201056.64 %14.74 %9.63 %
200956.04 %13.16 %8.1 %
200854.55 %12 %5.07 %
200754.16 %9.78 %6.37 %
200655.93 %11.79 %8.11 %
200554.74 %9.76 %6.91 %
200455.97 %11.32 %6.26 %

Bio Rad Laboratories Stock Sales Revenue, EBIT, Earnings per Share

The Bio Rad Laboratories earnings per share therefore indicates how much revenue Bio Rad Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bio Rad Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bio Rad Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bio Rad Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bio Rad Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Bio Rad Laboratories Revenue, EBIT and net profit per share

DateBio Rad Laboratories Sales per ShareBio Rad Laboratories EBIT per shareBio Rad Laboratories Earnings per Share
2028e108.54 undefined0 undefined13.51 undefined
2027e104.36 undefined0 undefined12.53 undefined
2026e101.04 undefined0 undefined13.21 undefined
2025e96.43 undefined0 undefined11.77 undefined
2024e93.07 undefined0 undefined10.38 undefined
202391.45 undefined12.52 undefined-21.82 undefined
202294.03 undefined16.34 undefined-121.73 undefined
202196.77 undefined18.7 undefined140.87 undefined
202084.29 undefined13.95 undefined126.3 undefined
201976.55 undefined8.43 undefined58.24 undefined
201875.81 undefined6.46 undefined12.11 undefined
201772.01 undefined5.35 undefined4.07 undefined
201669.87 undefined4.41 undefined0.88 undefined
201568.69 undefined5.67 undefined3.85 undefined
201474.74 undefined5.15 undefined3.05 undefined
201373.8 undefined5.87 undefined2.69 undefined
201272.35 undefined9.24 undefined5.79 undefined
201172.75 undefined10.71 undefined6.28 undefined
201068.34 undefined10.07 undefined6.58 undefined
200964.18 undefined8.45 undefined5.2 undefined
200863.93 undefined7.67 undefined3.24 undefined
200753.52 undefined5.23 undefined3.41 undefined
200647.36 undefined5.58 undefined3.84 undefined
200544.23 undefined4.32 undefined3.06 undefined
200441.13 undefined4.66 undefined2.57 undefined

Bio Rad Laboratories business model

Bio-Rad Laboratories Inc. is a leading company in the field of scientific research based in Hercules, California. The company was founded in 1952 by two brothers and has since developed into a multinational company with over 8,000 employees worldwide. Bio-Rad has branches in over 100 countries and its products are used in biotechnology, pharmaceuticals, and the food industry. History Bio-Rad was founded in 1952 by the couple David and Alice Schwartz. They started with the production of blood group serology tests and later expanded their product range to include immunchemicals, electrophoresis equipment, and antibodies. In the 1970s, Bio-Rad developed the first commercial protein A purification system, which is still an important component of protein research today. Business model Bio-Rad's business model is focused on providing high-quality products and services to support customers in their scientific research. The company has various divisions such as life science research, clinical diagnostics, and life science education, which offer products and solutions for scientists, researchers, and diagnosticians. Life science research The life science research division offers a wide range of products and services for biological research. This includes PCR systems, electrophoresis equipment, antibodies, proteins, cell counters, and much more. Bio-Rad's products are used by scientists and researchers around the world to better understand the intricacies of life and the mechanisms of diseases. Clinical diagnostics Bio-Rad's clinical diagnostics division provides a broad spectrum of diagnostic products and solutions for hospitals, laboratories, and medical facilities. The company provides clinical diagnostic instruments, reagents, testing systems, and software to support the diagnostic process. Life science education The life science education division offers innovative and interactive teaching and learning materials for scientific research to teachers, professors, and students. Bio-Rad's products and solutions support the better understanding of the intricacies of life and the mechanisms of diseases in the fields of biology, chemistry, and physics. Products Bio-Rad offers a wide range of products and solutions for research and diagnostics. These include, among others: PCR systems: Bio-Rad offers various PCR systems that help researchers and diagnosticians amplify and analyze DNA. The systems are highly precise and provide reliable results. Proteins and antibodies: Bio-Rad offers a wide selection of proteins and antibodies for research and diagnostics. The products include various types of proteins and antibodies needed for the analysis of protein functions and interactions. Electrophoresis equipment: Bio-Rad provides various electrophoresis equipment that plays an important role in research and diagnostics. The products include gel electrophoresis systems, Western blot systems, and devices for protein analysis. Clinical diagnostics: Bio-Rad offers a wide range of diagnostic products for hospitals, laboratories, and medical facilities. These include immunoassay products, blood group serology tests, and devices for the diagnosis of infectious diseases. In summary, Bio-Rad Laboratories Inc. is a leading company in the field of scientific research. The company offers a wide range of products and solutions for research and diagnostics, supporting scientists, researchers, and diagnosticians around the world in exploring the intricacies of life and better understanding diseases. Bio Rad Laboratories is one of the most popular companies on Eulerpool.com.

Bio Rad Laboratories SWOT Analysis

Strengths

Bio Rad Laboratories Inc is a leading global provider of life science research and clinical diagnostics products. The company has an extensive product portfolio, ranging from instruments and reagents to software and services, catering to the needs of various scientific and healthcare professionals.

Bio Rad has a strong brand reputation and is recognized for its high-quality and innovative solutions. This reputation enables the company to attract and retain loyal customers in the highly competitive life sciences industry.

The company's research and development capabilities are a significant strength, as they allow Bio Rad to constantly introduce new products and technologies to meet changing market demands.

Weaknesses

Despite its strong market position, Bio Rad faces certain weaknesses. One of these weaknesses is its dependence on a limited number of key customers, which puts the company at risk if any of these customers reduce their purchasing volumes or switch to competitors.

Another weakness is the company's limited geographic diversification. Bio Rad operates primarily in the United States, making it vulnerable to fluctuations in the domestic market and potentially missing out on international growth opportunities.

Opportunities

Bio Rad has several opportunities for growth. The increasing global focus on healthcare and research presents opportunities for the company to expand its customer base and enhance market penetration. The growing demand for personalized medicine and genetic testing also offers new avenues for product development and revenue generation.

Furthermore, strategic partnerships and collaborations with other industry players or academic institutions can provide Bio Rad with access to complementary technologies and expertise, enabling the company to offer more comprehensive solutions to its customers.

Threats

The highly competitive nature of the life sciences industry poses a significant threat to Bio Rad. The company faces intense competition from both large multinational corporations and smaller specialized companies, which may have competitive advantages in certain niche markets.

Additionally, regulatory requirements and compliance challenges in the healthcare and life sciences sectors can pose risks and add complexity to Bio Rad's operations. Changes in regulations or failure to comply with existing ones may impact the company's ability to market and sell its products.

Bio Rad Laboratories Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Bio Rad Laboratories Revenue by Segment

Segmente20232022202120202019
Clinical Diagnostics1.49 B USD1.45 B USD1.52 B USD1.31 B USD1.41 B USD
Life Science1.18 B USD1.35 B USD1.4 B USD1.23 B USD-

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Bio Rad Laboratories Revenue by Segment

Segmente20232022202120202019
All Other Segments3.6 M USD4 M USD5.8 M USD8.6 M USD-

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Bio Rad Laboratories Revenue by Segment

Segmente20232022202120202019
Life Science----885.9 M USD
All Other Segments----13.8 M USD

Bio Rad Laboratories Revenue by Region

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Bio Rad Laboratories Revenue by Segment

DateAsiaEuropeOther (primarily Canada and Latin America)United States
2023563 M USD819.8 M USD166.6 M USD1.12 B USD
2022639.4 M USD851.9 M USD155.4 M USD1.16 B USD
2021688.4 M USD946.9 M USD156.6 M USD1.13 B USD
2020546.5 M USD857.7 M USD136.6 M USD1 B USD
2019505 M USD770.3 M USD137.3 M USD899.1 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Bio Rad Laboratories Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Bio Rad Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Bio Rad Laboratories shares outstanding

The number of shares was Bio Rad Laboratories in 2023 — This indicates how many shares 29.209 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bio Rad Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bio Rad Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bio Rad Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bio Rad Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Bio Rad Laboratories.

Bio Rad Laboratories latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20241.17 2.01  (72.06 %)2024 Q3
6/30/20242.03 3.11  (52.85 %)2024 Q2
3/31/20242.17 2.29  (5.67 %)2024 Q1
12/31/20232.85 3.1  (8.96 %)2023 Q4
9/30/20232.81 2.33  (-17.09 %)2023 Q3
6/30/20232.71 3  (10.88 %)2023 Q2
3/31/20233.58 3.34  (-6.64 %)2023 Q1
12/31/20223.48 3.31  (-4.96 %)2022 Q4
9/30/20222.81 2.6  (-7.47 %)2022 Q3
6/30/20222.83 3.38  (19.57 %)2022 Q2
1
2
3
4
5
...
10

Eulerpool ESG Scorecard© for the Bio Rad Laboratories stock

Eulerpool World ESG Rating (EESG©)

68/ 100

🌱 Environment

74

👫 Social

99

🏛️ Governance

30

Environment

Scope 1 - Direct Emissions
21,216
Scope 2 - Indirect emissions from purchased energy
15,092
Scope 3 - Indirect emissions within the value chain
295,930
Total CO₂ emissions
36,308
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees44
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Bio Rad Laboratories shareholders

%
Name
Stocks
Change
Date
8.44965 % The Vanguard Group, Inc.2,365,903-46,2616/30/2024
6.37338 % Alice N. Schwartz Revocable Trust1,784,546-3,2702/26/2024
4.65626 % Van Eck Associates Corporation1,303,752644,5309/30/2024
3.88028 % Veritas Asset Management LLP1,086,479-42,3329/30/2024
3.67233 % BlackRock Institutional Trust Company, N.A.1,028,25321,7316/30/2024
3.38902 % Schwartz (Alice N)948,9272,0702/26/2024
3.07104 % State Street Global Advisors (US)859,891-13,7846/30/2024
2.31972 % Select Equity Group, L.P.649,522134,8566/30/2024
2.27241 % First Eagle Investment Management, L.L.C.636,275634,3116/30/2024
2.16710 % EARNEST Partners, LLC606,78891,8826/30/2024
1
2
3
4
5
...
10

Bio Rad Laboratories Executives and Management Board

Mr. Norman Schwartz

(73)
Bio Rad Laboratories Chairman of the Board, President, Chief Executive Officer, Interim Principal financial officer (since 1995)
Compensation 7.53 M

Dr. Andrew Last

(63)
Bio Rad Laboratories Chief Operating Officer, Executive Vice President
Compensation 3.37 M

Mr. Michael Crowley

(61)
Bio Rad Laboratories Executive Vice President - Global Commercial Operations
Compensation 2.68 M

Dr. Simon May

(51)
Bio Rad Laboratories Executive Vice President, President - Life Science Group
Compensation 2.14 M

Mr. Gregory Hinckley

(76)
Bio Rad Laboratories Lead Independent Director
Compensation 161,000
1
2
3

Bio Rad Laboratories Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Quantum-Si A Stock
Quantum-Si A
SupplierCustomer0,970,580,610,840,64
Scientech Corporation Stock
Scientech Corporation
SupplierCustomer0,940,430,77-0,04-0,560,14
Danaher Corporation Stock
Danaher Corporation
SupplierCustomer0,890,850,920,920,900,87
Seegene, Inc. Stock
Seegene, Inc.
SupplierCustomer0,780,540,580,820,54
Chembio Diagnostics Stock
Chembio Diagnostics
SupplierCustomer0,600,750,880,920,72-0,29
Luminex Corporation Stock
Luminex Corporation
SupplierCustomer0,580,46-0,25-0,89-0,90
Sartorius Vz Stock
Sartorius Vz
SupplierCustomer0,390,510,860,960,960,94
bioMerieux Stock
bioMerieux
SupplierCustomer0,360,170,690,950,70-0,18
Level Biotechnology Inc. Stock
Level Biotechnology Inc.
SupplierCustomer0,350,14-0,07-0,080,02-0,31
DCC plc Stock
DCC plc
SupplierCustomer-0,09-0,43
1

Most common questions regarding Bio Rad Laboratories

What values and corporate philosophy does Bio Rad Laboratories represent?

Bio Rad Laboratories Inc represents a strong set of values and a dedicated corporate philosophy. The company is committed to providing innovative solutions and high-quality products in the life sciences and clinical diagnostics fields. Bio Rad prioritizes excellence, integrity, and teamwork in all its endeavors. With a focus on customer satisfaction, Bio Rad strives to deliver superior value and support to its clients. The company's relentless dedication to scientific advancement and commitment to ethical and responsible business practices contribute to its reputable standing in the industry.

In which countries and regions is Bio Rad Laboratories primarily present?

Bio Rad Laboratories Inc is primarily present in the United States, with its headquarters located in Hercules, California. Aside from its domestic presence, Bio Rad operates internationally in various countries and regions. This includes Europe (with offices in the United Kingdom, France, Germany, and other countries), Asia-Pacific (including Japan, China, Korea, and Australia), Latin America, and Canada. With its extensive global footprint, Bio Rad Laboratories Inc continues to expand its reach and serve customers worldwide in the life sciences and clinical diagnostics industries.

What significant milestones has the company Bio Rad Laboratories achieved?

Bio Rad Laboratories Inc has accomplished several significant milestones. From its inception in 1952, the company has become a global leader in life science research and clinical diagnostics. One noteworthy achievement is the development of ground-breaking products, such as the first digital imaging system for electrophoresis analysis, which revolutionized the field. Bio Rad also played a crucial role in advancing HIV/AIDS diagnostics and monitoring through the introduction of reliable testing systems. Additionally, the company's continuous dedication to innovation has led to expansions in various areas, including food safety and quality control, further strengthening its position as a trusted provider of scientific solutions across industries. Bio Rad Laboratories Inc remains committed to driving advancements and enhancing scientific research globally.

What is the history and background of the company Bio Rad Laboratories?

Bio Rad Laboratories Inc, established in 1952, is a global leader in life science research and clinical diagnostics. The company's rich history spans over several decades, during which it has consistently provided innovative solutions to scientists and healthcare professionals. Bio Rad initially focused on the development of specialized products for the growing field of biochemical research, and later expanded into medical diagnostics and life science technologies. Today, Bio Rad continues to deliver cutting-edge technology, spanning areas such as genomics, proteomics, cell biology, food safety, and more. With a commitment to excellence and advancements in healthcare, Bio Rad Laboratories Inc remains a trusted name in the scientific community.

Who are the main competitors of Bio Rad Laboratories in the market?

Some of the main competitors of Bio Rad Laboratories Inc in the market include Thermo Fisher Scientific Inc, PerkinElmer Inc, and Illumina Inc.

In which industries is Bio Rad Laboratories primarily active?

Bio Rad Laboratories Inc operates primarily in the Life Sciences and Clinical Diagnostics industries. As a leading global provider of specialty diagnostic solutions, Bio Rad offers a wide range of products and services for scientific research and healthcare diagnostics. The company specializes in developing and manufacturing instruments, reagents, software, and consumables for applications in life science research, clinical laboratories, and pharmaceutical production. With a focus on advancing scientific discovery and improving patient healthcare, Bio Rad Laboratories Inc plays a crucial role in the fields of molecular biology, genomics, proteomics, and more.

What is the business model of Bio Rad Laboratories?

The business model of Bio Rad Laboratories Inc. revolves around refining and providing innovative solutions for the life science research and diagnostic markets. As a leading global provider of products and systems, Bio Rad Laboratories Inc. focuses on developing and manufacturing a wide range of specialized products. These include instruments, reagents, consumables, software, and services that cater to medical diagnostics, scientific research, and biopharmaceutical production. By continuously investing in research and development, Bio Rad Laboratories Inc. aims to meet the diverse needs of its customers, drive scientific advancements, and improve patient outcomes worldwide.

What is the P/E ratio of Bio Rad Laboratories 2024?

The Bio Rad Laboratories P/E ratio is 33.8.

What is the P/S ratio of Bio Rad Laboratories 2024?

The Bio Rad Laboratories P/S ratio is 3.77.

What is the Quality Investing of Bio Rad Laboratories?

The Quality Investing for Bio Rad Laboratories is 3/10.

What is the revenue of Bio Rad Laboratories 2024?

The expected Bio Rad Laboratories revenue is 2.61 B USD.

How high is the profit of Bio Rad Laboratories 2024?

The expected Bio Rad Laboratories profit is 290.56 M USD.

What is the business model of Bio Rad Laboratories

Bio Rad Laboratories Inc is a globally operating company in the field of life science research, diagnostics, and biopharmaceuticals. The company offers a wide range of innovative products and services for research institutions, biotechnology and pharmaceutical companies, as well as customers in clinical diagnostics. The business strategy of Bio Rad Laboratories is based on three pillars: product innovation, diversification, and global expansion. The company continuously invests in research and development to develop new products and services that meet the needs of its customers. Thanks to the diversification of its product lines, Bio Rad Laboratories is able to expand in various areas of life sciences and address a wide spectrum of customers. The company is divided into six main business areas: 1. Life Science Research Bio Rad Laboratories offers a comprehensive range of life science research products for research in genomics, proteomics, cell biology, and immunology. Products include DNA isolation kits, PCR reagents, protein separation systems, and antibody solutions. 2. Diagnostics Bio Rad Laboratories is a leading provider of in vitro diagnostics and QC/QA products. The company offers diagnostic products for clinical chemistry, hematology, immunology, and microbiology. 3. Biopharma Bio Rad Laboratories offers a wide range of solutions for biopharmaceuticals, including chromatography columns, protein purification systems, and analysis equipment. 4. Food Science Bio Rad Laboratories offers products for food quality assurance. This includes products for the identification of contaminants in food, such as salmonella, E. coli, and other bacterial contaminations, as well as for testing the nutrient quality in food. 5. Process Separations Bio Rad Laboratories offers a comprehensive range of chromatography columns and accessories used for downstream purification of proteins and other biomolecules in biopharmaceuticals and the food industry. 6. Digital Biology Bio Rad Laboratories offers solutions for digital PCR analysis with its droplet digital PCR technology. This technology allows for the quantification of nucleic acids on an absolute basis and can be used in numerous applications in research and diagnostics. The company also offers software solutions that simplify and standardize data recording and analysis in laboratory tests. The offered software solutions include laboratory information management systems (LIMS), chromatography software, and data analysis tools. Bio Rad Laboratories' customers include research institutions, biotechnology and pharmaceutical companies, as well as customers in clinical diagnostics. The company's products and services are sold in over 100 countries worldwide. In conclusion, Bio Rad Laboratories offers a wide portfolio of products and services in the field of life science research, diagnostics, and biopharmaceuticals. The company pursues a business strategy based on product innovation, diversification, and global expansion. Thanks to the wide range of products and services designed for different business areas, Bio Rad Laboratories is able to serve a broad spectrum of customers worldwide.

What is the Bio Rad Laboratories dividend?

Bio Rad Laboratories pays a dividend of 0 USD distributed over payouts per year.

How often does Bio Rad Laboratories pay dividends?

The dividend cannot currently be calculated for Bio Rad Laboratories or the company does not pay out a dividend.

What is the Bio Rad Laboratories ISIN?

The ISIN of Bio Rad Laboratories is US0905722072.

What is the Bio Rad Laboratories WKN?

The WKN of Bio Rad Laboratories is 865406.

What is the Bio Rad Laboratories ticker?

The ticker of Bio Rad Laboratories is BIO.

How much dividend does Bio Rad Laboratories pay?

Over the past 12 months, Bio Rad Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bio Rad Laboratories is expected to pay a dividend of 0 USD.

What is the dividend yield of Bio Rad Laboratories?

The current dividend yield of Bio Rad Laboratories is .

When does Bio Rad Laboratories pay dividends?

Bio Rad Laboratories pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bio Rad Laboratories?

Bio Rad Laboratories paid dividends every year for the past 0 years.

What is the dividend of Bio Rad Laboratories?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bio Rad Laboratories located?

Bio Rad Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bio Rad Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bio Rad Laboratories from 12/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/15/2024.

When did Bio Rad Laboratories pay the last dividend?

The last dividend was paid out on 12/15/2024.

What was the dividend of Bio Rad Laboratories in the year 2023?

In the year 2023, Bio Rad Laboratories distributed 0 USD as dividends.

In which currency does Bio Rad Laboratories pay out the dividend?

The dividends of Bio Rad Laboratories are distributed in USD.

All fundamentals about Bio Rad Laboratories

Our stock analysis for Bio Rad Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio Rad Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.